Risk assessment of soybean-based phytoestrogens

Journal of Toxicology and Environmental Health - Part A: Current Issues

Volumn 72, Issue 21-22, 2009, Pages 1254-1261

  Kwack, Seung Jun ^a   Kim, Kyu Bong ^a   Kim, Hyung Sik ^b   Yoon, Kyung Sil ^c   Lee, Byung Mu ^d  

^a National Institute of Toxicological Research   (South Korea)

^b Pusan National University   (South Korea)

^c National Cancer Center   (South Korea)

^d Sungkyunkwan University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; BIOCHANIN A; CHLORPHENOTANE; CIPERMETHRIN; COUMESTROL; DAIDZEIN; DIELDRIN; ENDOCRINE DISRUPTOR; ESTRADIOL; FORMONONETIN; GENISTEIN; LINDANE; NONYLPHENOL; PHTHALIC ACID BENZYL BUTYL ESTER; PHYTOESTROGEN; SOYBEAN OIL;

ADULT; ARTICLE; BINDING AFFINITY; COHORT ANALYSIS; DIETARY INTAKE; ESTROGEN ACTIVITY; FOOD INTAKE; FOOD SAFETY; HEALTH HAZARD; HUMAN; JAPAN; KOREA; PHYTOTOXICITY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SOYBEAN; WESTERN HEMISPHERE; CHEMICAL STRUCTURE; CHEMISTRY; DIET; ENVIRONMENTAL EXPOSURE; MIDDLE AGED;

GLYCINE MAX;

DIET; ENVIRONMENTAL EXPOSURE; HUMANS; KOREA; MIDDLE AGED; MOLECULAR STRUCTURE; PHYTOESTROGENS; RISK FACTORS; SOYBEANS;

EID: 75749136523     PISSN: 15287394     EISSN: 10872620     Source Type: Journal    
DOI: 10.1080/15287390903212212     Document Type: Article

References (96)

1. Adlercreutz, H. 1995. Phytoestrogens: Epidemiology and possible role in cancer prevention. Environ. Health Perspect. 103 (Suppl. 7): 103-112.
2. Adlercreutz, H. 1998. Epidemiology of phytoestrogens. Baillieres Clin. Endocrinol. Metab. 12: 604-623.
3. Adlercreutz, H. 2002. Phyto-oestrogens and cancer. Lancet Oncol. 3: 364-373.
4. Adlercreutz, H., and Mazur, M. 1997. Phyto-estrogens and Western diseases. Ann. Med. 29: 95-120.
5. Arai, Y., Uehara, M., Sato, Y., Kimira, M., Eboshida, A., Adlercreutz, H., and Watanabe, S. 2000. Comparison of isoflavones among dietary intake, plasma concentration and urinary excretion for accurate estimation of phytoestrogen intake. J. Epidemiol. 10: 127-135.
6. ATSDR. 2005. Toxicological profile for hexachlorocyclohexanes (Update). Washington, DC: U.S. Department of Health & Human Services, Public Health Service, Agency for Toxic Substances and Disease Registry.
7. Bakke, D. 2003. Human and ecological risk assessment of nonylphenol polyethoxylate-based (NPE) surfactants in Forest Service herbicide applications. Vallejo, CA: USDA Forest Service Pacific Southwest Region (Region 5) (May 2003).
8. Barrett, J. 1996. Phytoestrogens: Friends or foes? Environ. Health Perspect. 104: 478-482.
9. Behnisch, P. A., Fujii, K., Shiozaki, K., Kawakami, I., and Sakai, S. 2001. Estrogenic and dioxin-like potency in each step of a controlled landfill leachate treatment plant in Japan. Chemosphere 43: 977-984.
10. Belcher, S. M., and Zsarnovszky, A. 2001. Estrogenic actions in the brain: Estrogen, phytoestrogens, and rapid intracellular signaling mechanisms. J. Pharmacol. Exp. Ther. 299: 408-414.
11. Bern, H. A. 1992. The fragile fetus. In Advances in modern environmental toxicology, vol.XXI, Chemically-induced alterations in sexual and functional development: The wildlife/human connection, eds. T. Colborn and C. Clement, pp. 9-15. Princeton, NJ: Princeton Scientific.
12. Bickoff, E. M., Livingston, A. L., Hendrickson, A. P., and Booth, A. N. 1962. Relative potencies of several estrogen-like compounds found in forages. Agric. Food Chem. 10: 410-412.
13. Boker, L. K., Van der Schouw, Y. T., De Kleijn, M. J., Jacques, P. F., Grobbee, D. E., and Peeters, P. H. 2002. Intake of dietary phytoestrogens by Dutch women. J. Nutr. 132: 1319-1328.
14. Bolt, H. M., Janning, P., Michna, H., and Degen, G. H. 2001. Comparative assessment of endocrine modulators with oestrogenic activity: I. Definition of a hygiene-based margin of safety (HBMOS) for xeno-oestrogens against the background of European developments. Arch. Toxicol. 74: 649-662.
15. Brouns, F. 2002. Soya isoflavones: A new and promising ingredient for the health foods sector. Food Res. Int. 35: 187-193.
16. Cassady, J. M., Baird, W. M., and Chang, C. J. 1990. Natural products as a source of potential cancer chemotherapeutic and chemopreventive agents. J. Nat. Prod. 53: 23-41.
17. Cassidy, A. 1996. Physiological effects of phyto-oestrogens in relation to cancer and other human health risks. Proc. Nutr. Soc. 55: 399-417.
18. Cassidy, A. 2003. Potential risks and benefits of phytoestrogen-rich diets. Int. J. Vitam. Nutr. Res. 73: 120-126.
19. Chang, H. C., Churchwell, M. I., Delclos, K. B., Newbold, R. R., and Doerge, D. R. 2000. Mass spectrometric determination of genistein tissue distribution in diet-exposed Sprague-Dawley rats. J. Nutr. 130: 1963-1970.
20. Choi, S. M., Yoo, S. D., and Lee, B. M. 2004. Toxicological characteristics of endocrine-disrupting chemicals: Developmental toxicity, carcinogenicity, and mutagenicity. J. Toxicol. Environ. Health B 7: 1-23.
21. Colborn, T., vom Saal, F. S., and Soto, A. M. 1993. Developmental effects of endocrine-disrupting chemicals in wildlife and humans. Environ. Health Perspect. 101: 378-384.
22. Committee on Toxicity of Chemicals in Food, Consumer Products and the Environment. 2003. Phytoestrogens and health, ed. I. Hughes. London: Food Standards Agency.
23. Danzo, B. J. 1997. Environmental xenobiotics may disrupt normal endocrine function by interfering with the binding of physiological ligands to steroid receptors and binding proteins. Environ. Health Perspect. 105: 294-301.
24. Das, S. K., Tan, J., Johnson, D. C., and Dey, S. K. 1998. Differential spatiotemporal regulation of lactoferrin and progesterone receptor genes in the mouse uterus by primary estrogen, catechol estrogen, and xenoestrogen. Endocrinology 139: 2905-2915.
25. David, R. M. 2000. Exposure to phthalate esters. Environ. Health Perspect. 108: A440.
26. De Kleijn, M. J., Van der Schouw, Y. T., Wilson, P. W., Adlercreutz, H., Mazur, W., Grobbee, D. E., and Jacques, P. F. 2001. Intake of dietary phytoestrogens is low in postmenopausal women in the United States: The Framingham study (1-4). J. Nutr. 131: 1826-1832.
27. DeRosa, C., Richter, P., Pohl, H., and Jones, D. E. 1998. Environmental exposures that affect the endocrine system: Public health implications. J. Toxicol. Environ. Health B 1: 3-26.
28. Diel, P., Schulz, T., Smolnikar, K., Strunck, E., Vollmer, G., and Michna, H. 2000. Ability of xeno-and phytoestrogens to modulate expression of estrogen-sensitive genes in rat uterus: Estrogenicity profiles and uterotropic activity. J. Steroid Biochem. Mol. Biol. 73: 1-10.
29. Dogheim, S. M., El-Karka, M., Gad Allah, S. A., El-Sayed, S., Salma, E. Y., Ayoub, M. M., and Fahmy, S. M. 1996. Monitoring of pesticides residues in human milk, soil, water and food samples collected from Kafr El-Zayat Governorate. J. Assoc. Off. Anal. Chem. 79: 111-116.
30. Duffy, C., Perez, K., and Partridge, A. 2007. Implications of phytoestrogen intake for breast cancer. CA Cancer J. Clin. 57: 260-277.
31. European Commission. 2001. European Union risk-assessment report, vol.10, 2002, on 4-nonylphenol (branched) and nonylphenol. Ispra, Italy: European Chemicals Bureau, Joint Research Centre, European Commission. http: //ecb.jrc.it/existing-chemicals (under: existing-chemicals\risk-assessment\ report).
32. European Food Safety Authority. 2006. European Food Safety Authority: Opinion of the Scientific Panel on Food Additives, Flavourings, Processing Aids and Materials in Contact with Food on a request from the Commission related to 2,2-bis(4-hydroxyphenyl) propane (bisphenol A). http: //www.efsa.europa.eu/ EFSA/efsa-locale-1178620753812-1178620772817.htm.
33. Eldridge, A., and Kwolek, W. F. 1983. Soybean isoflavones: Effect of environment and variety on composition. J. Agric. Food Chem. 31: 394-396.
34. Fang, M. Z., Chen, D., Sun, Y., Jin, Z., Christman, J. K., and Yang, C. S. 2005. Reversal of hypermethylation and reactivation of p16INK4a, RARh, and MGMT genes by genistein and other isoflavones from soy. Clin. Cancer. Res. 11: 7033-7041.
35. Franke, A. A., Custer, L. J., and Tanaka, Y. 1998a. Isoflavones in human breast milk and other biological fluids. Am. J. Clin. Nutr. 68(suppl.): 1466S-1473S.
36. Franke, A. A., Custer, L. J., Wang, W., and Shi, C. Y. 1998b. HPLC analysis of isoflavonoids and other phenolic agents from foods and from human fluids. Proc. Soc. Exp. Biol. Med. 217: 263-273.
37. Gooderham, M. J., Adlercreutz, H., Ojala, S., Wähäla, K., and Holub, B. J. 1996. A soy protein isolate rich in genistein and daidzein and its effects on plasma isoflavones concentrations, platelet aggregation, blood lipids and fatty acid composition of plasma phospholipid in normal men. J. Nutr. 126: 2000-2006.
38. Gunderson, E. L. 1995a. Dietary intakes of pesticides, selected elements, and other chemicals: FDA total diet study, June 1984-April 1986. J. Assoc. Off. Anal. Chem. 78: 910-921.
39. Gunderson, E. L. 1995b. FDA total diet study, July 1986-April 1991, dietary intakes of pesticides, selected elements, and other chemicals. J. Assoc. Off. Anal. Chem. 78: 1353-1363.
40. Hargreaves, D. F., Potten, C. S., Harding, C., Shaw, L. E., Morton, M. S., Roberts, S. A., Howell, A., and Bundred, N. J. 1999. Two-week dietary soy supplementation has an estrogenic effect on normal premenopausal breast. J. Clin. Endocrinol. Metab. 84: 4017-4024.
41. Heald, C. L., Bolton-Smith, C., Ritchie, M. R., Morton, M. S., and Alexander, F. E. 2006. Phyto-oestrogen intake in Scottish men: Use of serum to validate a self-administered food-frequency questionnaire in older men. Eur. J. Clin. Nutr. 60: 129-135.
42. IRIS. 2004. DDT. Integrated Risk Information System, Database quest, last revised: 02/01/1996 (cancer: 05/01/1991). U.S. Environmental Protection Agency.
43. IRIS. 2009. Cypermethrin. Integrated Risk Information System, Database quest, last revised: 01/01/1990. U.S. Environmental Protection Agency. http: //www.epa.gov/iris/subst/0380.htm
44. Joint FAO/WHO Expert Committee on Food Additives. 1999. Joint FAO/ WHO Expert Committee on Food Additives. Summary and Conclusions of the Fifty-second Meeting, Rome, 2-11 February 1999. http: //www.fao.org/ WAICENT/FAOINFO/ ECONOMIC/ESN/Jecfa/jecfa52.pdf.
45. Joint FAO/WHO Meeting on Pesticide Residues. 1977. Aldrin/dieldrin. Pesticide residues in food, 1977. http: //www.inchem.org/documents/jmpr.
46. Joint FAO/WHO Meeting on Pesticide Residues. 1997. Lindane. Pesticide residues in food, 1997. http: //www.inchem.org/documents/jmpr.
47. Joyeux, A., Balaguer, P., Germain, P., Boussieux, A. M., Pons, M., and Nicolas, J. C. 1997. Engineered cell lines as a tool for monitoring biological activity of hormone analogs. Anal. Biochem. 249: 119-130.
48. Korea Health Industry Development Institute. 2006. The Third Korea National Health & Nutrition Examination Survey (KNHANES III), 2005. KHIDI Publication No. 11-1460000-000529-612 Seoul: Korea Health Industry Development Institute, Ministry for Health, Welfare and Family Affairs.
49. Kim, H. S., Kang, T. S., Kang, I. H., Kim, T. S., Moon, H. J., Kim, I. Y., Ki, H., Park, K. L., Lee, B. M., Yoo, S. D., and Han, S. Y. 2005. Validation study of OECD rodent uterotropic assay for the assessment of estrogenic activity in Sprague-Dawley immature female rats. J. Toxicol. Environ. Health A 68: 2249-2262.
50. King, R. A., Broadbent, J. L., and Head, R. J. 1996. Absorption and excretion of the soy isoflavone genistein in rats. J. Nutr. 126: 176-182.
51. Kirk, P., Patterson, R.E., and Lampe, J. 1999. Development of a soy food frequency questionnaire to estimate isoflavone consumption in US adults. J. Am. Diet. Assoc. 99: 558-563.
52. Kojima, H., Katsura, E., Takeuchi, S., Niiyama, K., and Kobayashi, K. 2004. Screening for estrogen and androgen receptor activities in 200 pesticides by in vitro reporter gene assays using Chinese hamster ovary cells. Environ. Health Perspect. 112: 524-531.
53. Koo, H. J., and Lee, B. M. 2005. Human monitoring of phthalates and risk assessment. J. Toxicol. Environ. Health A 68: 1379-1392.
54. Kuiper, G. C., Carlsson, B., Grandien, K. Enmark, E., Haggblad, J., Nilsson, S., and Gustafsson, J. Å. 1997. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 138: 863-870. (Pubitemid 27089735)
55. Kuiper, G. G., Lemmen, J. G., Carsson, B., Corton B., Safe, S. H., van der Saag, P. T., van der Burg, B., and Gustafsson, J. Å. 1998. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor . Endocrinology 139: 4252-4263.
56. Kurzer, M., and Xu, X. 1997. Dietary phytoestrogens. Annu. Rev. Nutr. 17: 353-381.
57. Lamartiniere, C. A., Zhang, J.-X, and Cotroneo, M. S. 1998. Genistein studies in rats: Potential for breast cancer prevention and reproductive and developmental toxicity. Am. J. Clin. Nutr. Suppl.: 1400S-1405S.
58. Lee, B. M., and Park, K. K. 2003. Beneficial and adverse effects of chemopreventive agents. Mutat. Res. 523-524: 265-278.
59. Lee, J. B., Shin, J. S., Lee, H. D., Jeong, M. H., You, A. S., and Kang, K. Y. 2004. Risk assessment for estrogenic effect of the suspected endocrine disrupting pesticides. Korean J. Pestic. Sci. 8: 95-102.
60. Li, C., Teng, R. H., Tsai, Y. C., Ke, H. S., Huang, J. Y., Chen, C. C., Kao, Y. L., Kuo, C. C., Bell, W. R., and Shieh, B. 2005. H-ras oncogene counteracts the growth inhibitory effect of genistein in T4 bladder carcinoma cells. Br. J. Cancer 92: 80-88.
61. Limer, J. L., and Speirs, V. 2004. Phyto-oestrogens and breast cancer chemoprevention. Breast Cancer Res. 6: 119-127.
62. Lindsay, J., and Korach, K. S. 1998. Molecular actions of steroids: The estrogen receptor knockout mouse as a model for the study of endocrine disruptors, pp. 27-33. UBA Texte no. 50. Berlin: Umweltbundesamt.
63. Mäkelä, S., Hyder, S. M., and Stancel, G. M. 1999. Environmental estrogens. In Estrogens and antiestrogens, Handbook of experimental pharmacology, vol.135/II, eds. M. Oettel and E. Schillinger, pp. 613-663. New York: Springer.
64. Mazur, W. 1998. Phytoestrogen content in foods. Baillieres Clin. Endocrinol. Metabol. 12: 729-742.
65. Messina, M., Kucuk, O., and Lampe, J. W. 2006. An overview of the health effects of isoflavones with an emphasis on prostate cancer risk and prostatespecific antigen levels. J. Assoc. Off. Am. Chem. Int. 89: 1121-1134.
66. Michael McClain, R., Wolz, E., Davidovich, A., Pfannkuch, F., Edwards, J. A., and Bausch, J. 2006. Acute, subchronic and chronic safety studies with genistein in rats. Food Chem. Toxicol. 44: 56-80.
67. Morton, M. S., Wilcox, G., Wahlqvist, M. L., and Griffiths, K. 1994. Determination of lignans and isoflavonoids in human female plasma following dietary supplementation. J. Endocrinol. 142: 251-259.
68. Morton, M. S., Chan, P. S. F., Cheng, C., Blacklock, N., Matos-Ferreira, A., Abranches-Monteiro, L., Correia, R., Lloyd, S., and Griffith, K. 1997. Lignans and isoflavonoids in plasma and prostatic fluid in men: Samples from Portugal, Hong Kong, and the United Kingdom. Prostate 22: 122-128.
69. Mueller, S. O., Simon, S., Chae, K., Metzler, M., and Korach, K. S. 2004. Phytoestrogens and their human metabolites show distinct agonistic and antagonistic properties on estrogen receptor alpha (ERa) and ERb in human cells. Toxicol. Sci. 80: 14-25.
70. Mulligan, A. A., Welch, A. A., McTaggart, A. A., Bhaniani, A., and Bingham, S. A. 2007. Intakes and sources of soya foods and isoflavones in a UK population cohort study (EPIC-Norfolk). Eur. J. Clin. Nutr. 61: 248-254.
71. Newbold, R. R. 1995. Cellular and molecular effects of developmental exposure to diethylstilbestrol: Implications for other environmental estrogens. Environ. Health Perspect. 103(suppl. 7): 83-87.
72. National Toxicology Program. 2008. Multigenerational reproductive toxicology study of genistein (CAS NO. 446-72-0) in Sprague-Dawley rats (Feed sudy). Technical report series no. 539. NIH publication no. 08-4477. Research Triangle Park, NC: National Institutes of Health, Public Health Service, U.S. DHHS.
73. Petrakis, N. L., Barnes, S., King, E. B., Lowenstein, J., Wiencke, J., Lee, M. M., Miike, R., Kirk, M., and Coward, L. 1996. Stimulatory influence of soy protein isolate on breast secretion in pre-and postmenopausal women. Cancer Epidemiol. Biomarkers Prev. 5: 785-794.
74. Phillips, K. P., and Tanphaichitr, N. 2008. Human exposure to endocrine disrupters and semen quality. J. Toxicol. Environ. Health B 11: 188-220.
75. Power, K. A., Ward, W. E., Chen, J. M., Saarinen, N. M., and Thompson, L. U. 2007. Flaxseed and soy protein isolate, alone and in combination, differ in their effect on bone mass, biomechanical strength, and uterus in ovariectomized nude mice with MCF-7 human breast tumor xenografts. J. Toxicol. Environ. Health A 70: 1888-1896.
76. Reel, J. R., Lamb, J., and Neal, B. H. 1996. Survey and assessment of mammalian estrogen biological assays for hazard characterization. Fundam. Appl. Toxicol. 34: 288-305.
77. Reinli, K., and Block, G. 1996. Phytoestrogen content of foods-A compendium of literature values. Nutr. Cancer 26: 123-148.
78. Rogan, W. J., Gladen, B., Hung, K., Koong, S., Shih, L., Taylor, J. S., Wu, Y., Yang, D., Ragan, N. B., and Hsu, C. 1988. Congenital poisoning by polychlorinated biphenyls and their contaminants in Taiwan. Science 241: 334-336.
79. Sacks, F. M., Lichtenstein, A., Van Horn, L., Harris, W., Kris-Etherton, P., and Winston, M. 2006. Soy protein, isoflavones, and cardiovascular health: An American Heart Association Science Advisory for professionals from the Nutrition Committee. Circulation 113: 1034-1044. (Pubitemid 43879479)
80. Sakai, T., and Kogiso, M. 2008. Soy isoflavones and immunity. J. Med. Invest. 55: 167-173.
81. Setchell, K. D. R., Brown, N. M., Desai, P., Zimmer-Nechemias, L., Wolfe, B. E., Brashear, W. T., Kirschner, A. S., Cassidy, A., and Heubi, J. E. 2001. Bioavailability of pure isoflavones in healthy humans and analysis of commercial soy supplements. J. Nutr. 131: 1362S-1375S.
82. Setchell, K. D. R., Zimmer-Nechemias, L., Cai, J., and Heubi, J. E. 1997. Exposure of infants to phyto-oestrogens from soy-based infant formula. Lancet 350: 23-27.
83. Setchell, K. D. R., and Cassidy, A. 1999. Dietary isoflavones: Biological effects and relevance to human health. J. Nutr. 129: 758S-767S.
84. Sirtori, C. R. 2001. Risks and benefits of soy phytoestrogens in cardiovascular diseases, cancer, climacteric symptoms and osteoporosis. Drug Safety 24: 665-682.
85. Smeets, J. M., van Holsteijn, I., Giesy, J. P., Seinen, W., and van den Berg, M. 1999. Estrogenic potencies of several environmental pollutants, as determined by vitellogenin induction in a carp hepatocyte assay. Toxicol. Sci. 50: 206-213.
86. Stob, M. 1983. Naturally occurring food toxicants: Estrogens. In Handbook of naturally occurring food toxicants, ed M. Rechcigl, pp. 81-100. New York: CRC Press.
87. Surh, J., Kim, M. J., Koh, E., Kim, Y. K., and Kwon, H. 2006. Estimated intakes of isoflavones and coumestrol in Korean population. Int. J. Food Sci. Nutr. 57: 325-344.
88. Tham, D. M., Gardner, C. D., and Haskell, W. L. 1998. Potential health benefits of dietary phytoestrogens: A review of the clinical, epidemiological, and mechanistic evidence. J. Clin. Endocrinol. Metab. 83: 2223-2235.
89. Thompson, L. U., Boucher, B. A., Lui, Z., Cotterchio, M., and Kreiger, N. 2006. Phytoestrogen content of foods consumed in Canada, including isoflavones, lignans and coumestan. Nutr. Cancer 54: 184-201.
90. Trock, B. J., Hilakivi-Clarke, L., and Clarke, R. 2006. Meta-analysis of soy intake and breast cancer risk. JNCI 98: 459-471.
91. U.S. Environmental Protection Age ncy. 2008. Integrated Risk Information System (IRIS). Cincinnati, OH: Environmental Criteria and Assessment Office, Office of Health and Environmental Assessment, U.S. Environmental Protection Agency.
92. Wakai, K., Egami, I., Kato, K., Kawamura, T., Tamakoshi, A., Lin, Y., Nakayama, T., Wada, M., and Ohno,Y. 1999. Dietary intake and sources of isoflavones among Japanese. Nutr. Cancer 33: 139-145.
93. World Health Organization. 1989. Aldrin and dieldrin. Environmental Health Criteria 91. World Health Organisation, International Programme on Chemical Safety, Geneva.
94. World Health Organization. 1996. Aldrin and dieldrin. In Guidelines for drinking-water quality, 2nd ed., vol.2, pp. 602-608. Geneva: World Health Organization.
95. Williamson-Hughes, P. S., Flickinger, B. D., Messina, M. J., and Empie, M. W. 2006. Isoflavone supplements containing predominantly genistein reduce hot flash symptoms: A critical review of published studies. Menopause 13: 831-839.
96. Zacharewski, T. 1997. In vitro bioassays for assessing estrogenic substances. Environ. Sci. Technol. 31: 613-623.